![](https://techstory.in/wp-content/uploads/2024/07/GettyImages-123081795.webp)
Eli Lilly & Co. to buy U.S. gut-drug maker Morphic Holding Inc. for $3.2 billion Lilly Acquires US Biotech Morphic for ...
Eli Lilly & Co., a global leader in pharmaceuticals, has announced the acquisition of Morphic Holding Inc., a US-based biotech company specializing in treatments for gut diseases. This $3.2 billion deal marks a strategic investment for Lilly, aiming to …